✦ LIBER ✦

Co-enrollment in multiple HIV prevention trials — Experiences from the CAPRISA 004 Tenofovir gel trial

✍ Scribed by Quarraisha Abdool Karim; Ayesha B.M. Kharsany; Kasavan Naidoo; Nonhlanhla Yende; Tanuja Gengiah; Zaheen Omar; Natasha Arulappan; Koleka P. Mlisana; Londiwe R. Luthuli; Salim S. Abdool Karim

Book ID: 116350985
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 363 KB
Volume: 32
Category: Article
ISSN: 1551-7144
DOI: 10.1016/j.cct.2011.01.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Assessing Adherence in the CAPRISA 004 T

Assessing Adherence in the CAPRISA 004 Tenofovir Gel HIV Prevention Trial: Results of a Nested Case–Control Study

✍ MacQueen, Kathleen M.; Weaver, Mark A.; van Loggerenberg, Francois; Succop, Stac 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 169 KB

Infrequent, low magnitude HIV-specific T

Infrequent, low magnitude HIV-specific T cell responses in HIV-uninfected participants in the 1% tenofovir microbicide gel trial (CAPRISA004)

✍ WA Burgers, TL Muller, A Kiravu, V Naranbhai, S Sibeko, L Werner… 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 77 KB

Sensitive Tenofovir Resistance Screening

Sensitive Tenofovir Resistance Screening of HIV-1 From the Genital and Blood Compartments of Women With Breakthrough Infections in the CAPRISA 004 Tenofovir Gel Trial

✍ Wei, X.; Hunt, G.; Abdool Karim, S. S.; Naranbhai, V.; Sibeko, S.; Abdool Karim, 📂 Article 📅 2014 🏛 University of Chicago Press 🌐 English ⚖ 361 KB

Safety of coitally administered tenofovi

Safety of coitally administered tenofovir 1% gel, a vaginal microbicide, in chronic hepatitis B virus carriers: Results from the CAPRISA 004 trial

✍ Baxter, Cheryl; Yende-Zuma, Nonhlanhla; Tshabalala, Phindile; Abdool Karim, Quar 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 709 KB